♟️ Wednesday 28 January 2026 Wed, 28 Jan 2026

Tasman Resources reports a robust cash position and a valuable stake in Eden Innovations, while gearing up for significant drilling programs at its South Australian projects in 2026.

dorsaVi has launched a multi-year collaboration with leading Asian research institutes to develop its proprietary RRAM technology at the 22-nanometer node, targeting AI-driven robotics and wearable applications.

Future Metals NL has outlined strategic initiatives to enhance its flagship Panton PGM Project, leveraging rising platinum group metal prices and new processing opportunities. Key work programs and management appointments position the company for accelerated development in 2026.

Stakk Limited has surged to an $8.53 million annual recurring revenue run-rate in 2025, propelled by its acquisition of Radical DBX and strong SaaS growth. The fintech’s strategic moves position it for breakeven and further expansion in 2026.

Aurelia Metals announces Managing Director Bryan Quinn will resign by July 2026, with a leadership search underway amid key project developments.

Element 25 Limited has made significant strides in advancing its Butcherbird Expansion Project in Western Australia, securing $60 million in funding and progressing key engineering and contract milestones. Simultaneously, the company moves closer to finalising financing for its US-based battery-grade manganese refinery.

Southern Cross Gold Consolidated Ltd has reported exceptional drill results from its Sunday Gold-Antimony Creek Project in Victoria, revealing a large, continuous high-grade gold-antimony deposit with strategic critical mineral value.

Chimeric Therapeutics reports encouraging clinical progress in its CAR-T and NK cell therapy trials, alongside FDA orphan drug designation and a strategic funding boost to propel development.

Viridis Mining and Minerals has achieved a critical environmental milestone for its Colossus Rare Earth Project in Brazil and secured significant financing commitments, positioning the project for construction in the second half of 2026.

Patrys Limited has acquired Reliis, gaining a promising injectable formulation of quetiapine aimed at treating delirium with a rapid FDA approval pathway. This move positions Patrys at the forefront of addressing a significant unmet medical need in critical care.

Patrys Limited has completed its acquisition of Reliis Pty Ltd, adding a promising injectable quetiapine program to its clinical pipeline and strengthening its board with two new directors.

Yojee Limited reports a robust cash reserve and significant progress in its MOSAIC platform beta testing, alongside new customer contracts and strategic leadership hires, setting the stage for its 2026 commercial rollout.

Gale Pacific has reported a stronger-than-expected first half for FY26, delivering EBITDA of $5.7 million and positive operating cash flow despite challenging market conditions. Strategic restructuring and cost efficiencies are driving improved financial health.

Volt Resources has made significant strides in its US graphite refinery project and secured major funding for its Bunyu Graphite Mine in Tanzania, positioning itself strongly in the critical minerals sector.

Imricor Medical Systems has achieved multiple world-first procedures using real-time MRI guidance for cardiac ablation, advancing clinical trials and regulatory progress amid a strategic commercial expansion.

Metro Mining delivered a record 6.2 million wet metric tonnes in 2025 shipments, supported by a strong cash position and nearing completion of legacy contracts. The company is poised for expanded production and improved margins in 2026 following operational and leadership changes.

Axel REE Limited reports a remarkable 145% increase in rare earth elements and 339% gallium resource growth at its Caladão Project, alongside a metallurgical breakthrough that could slash development costs through in-situ leaching.

American Rare Earths has successfully produced Mixed Rare Earths Oxide from its Halleck Creek ore, marking a key technical milestone. The company also updated its resource estimate and strengthened leadership as it advances towards becoming a major U.S. rare earths supplier.

Benz Mining Corp’s latest drilling at the Glenburgh Gold Project reveals ultra high-grade shallow gold lenses and extends a large-scale mineralised system, positioning Glenburgh as a promising new gold district in Western Australia.

Aurum Resources has reported further high-grade gold intercepts at its BMT3 deposit within the Boundiali Gold Project, reinforcing resource confidence ahead of key 2026 milestones. The company is advancing aggressive drilling and development plans backed by a strong cash position.

Boss Energy delivered a record uranium production quarter at its Honeymoon project, lowering cost guidance and initiating a new feasibility study to reshape its mining strategy.

Syrah Resources reported a strong Q4 2025 with a 34% rise in graphite production and a strategic edge from US tariffs on Chinese imports. The company advances its Vidalia anode material facility amid growing demand for natural graphite outside China.

Algorae Pharmaceuticals has advanced its AI drug discovery capabilities with the launch of AlgoraeOS v2 and secured key commercial partnerships, including a $3 million debt facility to support expansion in Australia and New Zealand.

Syrah Resources delivered a record quarter with a 34% rise in natural graphite production and advancing anode material qualification at its Vidalia facility, while navigating evolving US trade policies that could reshape its market dynamics.